S2
. Fluorescence-based kinetics measurement of the cycloaddition between tetrazoles 2-9 (10 μM) and excess amount of Sph in phosphate buffer/acetonitrile 
General Information
Solvents and chemicals were purchased from commercial sources and used directly without further purification. N  -Boc-lysine (BocK) was purchased from Chem-Impex (Cat. No. 00363). Flash chromatography was performed either manually with SiliCycle P60 silica gel (40-63 m, 60 Å) or Yamazen AKROS flash system equipped with SiliaSep HP pre-packed columns. 1 H NMR spectra were recorded with Inova-300, -400 or -500 MHz spectrometers. Chemical shifts were reported in ppm using TMS or deuterated solvents as internal standards (TMS, 0.00; CDCl 3 , 7.26; acetone-d 6 , 2.05; DMSO-d 6 , 2.50). Multiplicity was reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, brs = broad. 13 C NMR spectra were recorded at 75.4 MHz or 100 MHz, and chemical shifts were reported in ppm using deuterated solvents as internal standards (CDCl 3 , 77.0; acetone-d 6 , 30.0; DMSO-d 6 , 39.5). Fluorescence spectra were recorded on Horiba FluoroMax-4 spectrofluorometer using 1-cm quartz cuvette at 25 ºC. Low resolution mass spectrometry was performed on a Thermo LCQ mass spectrometer. Molecular geometry optimization and orbital energies of nitrile imine were obtained using DFT calculations at B3LYP/6-31G (d) level with Gaussian09 program. [S1] Scheme S1. Synthesis of tetrazole 2 4-(5-(2,6-Dibromophenyl)-2H-tetrazol-2-yl)benzonitrile (2a): To a solution of benzenesulfonohydrazide (103 mg, 0.6 mmol) in ethanol was added 2,6-dibromobenzaldehyde (158 mg, 0.6 mmol), and small amount of ethyl acetate to increase the solubility, and the mixture was stirred at room temperature for 6 hours. The solvent was removed under reduced pressure to give the sulfohydrazone intermediate as a white solid. Preparation of the diazonium salt: to a solution of 4-aminobenzonitrile (705 mg, 6.0 mmol) in ethanol/water (2:1) cooled with ice-water bath was added sequentially 2.0 mL concentrated HCl and 1.0 mL sodium nitrite (454 mg, 6.6 mmol) solution in water, and the mixture was stirred for 10 min. To a solution of the sulfohydrazone intermediate in pyridine (30 mL) cooled with ice-salt bath was added the freshly prepared diazonium salt, and the mixture was stirred while temperature was allowed to gradually rise to room temperature. After about 6 hours, the solvent was removed and DCM (50 mL) was added. The mixture was washed with 1 N HCl before the solvent was removed under reduced pressure. The residue was purified by silica gel flash chromatography using ethyl acetate/hexanes as eluent to give the title compound as a colorless solid (61 mg, 25% 18, 137.64, 135.65, 133.72, 130.84, 128.73, 121.21, 119.84, 117.69, 113.96, 112.88, 110.27, 83.29, 77.40, 76.98, 76.56, 29.68, 27.43 
5-(2,6-Dibromophenyl)-2-phenyl-2H-tetrazole

5-(2,6-Dibromophenyl)-2-(4-methoxyphenyl)-2H-tetrazole (5a):
Compound 5a was reported in our previous study, [S2] and synthesized using the same procedure with 35% yield: 1 H NMR (400 MHz, CDCl 3 ) δ 8.13 (d, J = 8.4 Hz, 2H), 7.69 (dd, J = 8.1, 0.7 Hz, 2H), 7.32-7.18 (m, 1H), 7.07 (d, J = 8.4 Hz, 2H), 3.90 (d, J = 0.5 Hz, 3H); 13 C NMR (100 MHz, CDCl 3 ) δ 163. 28, 160.68, 132.39, 131.87, 130.74, 130.30, 125.36, 121.50, 114.71, 55.67 
4-(5-(2,6-Dibromophenyl)-2H-tetrazol-2-yl)phenol (5b):
To a solution of tetrazole 5a (100 mg, 0.24 mmol) in DCM (15 mL) cooled with ice-water bath was slowly added boron tribromide (0.23 mL, 2.4 mmol), and the mixture was stirred at room temperature overnight. After cooling the reaction mixture with ice-water bath, 1 mL methanol was slowly added and the solution was concentrated. The residue was purified by silica gel flash chromatography to give the titled compound as a white solid (42 mg, 44%): 1 H NMR (400 MHz, acetone-d 6 ) δ 8.11 -7.99 (m, 2H), 7.88 (d, J = 8.1 Hz, 2H), 7.50 (t, J = 8.1 Hz, 1H), 7.18 -7.01 (m, 2H); 13 C NMR (CDCl 3 , 75 MHz) δ 163. 27, 159.11, 133.34, 132.20, 130.84, 129.33, 124.87, 121.64, 116.36 82, 149.50, 139.37, 135.76, 132.28, 132.04, 131.91, 130.78, 128.65, 128.49, 128.28, 120.99, 120.16, 120.01, 110.30, 83.30, 77.41, 76.98, 76.56, 27.41, 24.48 4-(5-(2,6-Dibromophenyl)-2H-tetrazol-2-yl)aniline (7a): To a solution of tetrazole 6a (100 mg, 0.22 mmol) in ethanol (15 mL) was added KOH (64 mg, 1.14 mmol) solution in water (2 mL), and the mixture was stirred as 100 C overnight. The solvent was removed and 5 mL water and DCM were used. The organic layer was separated and dried over Na 2 SO 4 . The organic solvent was removed under reduced pressure, and the residue was purified by silica gel flash chromatography using ethyl acetate/hexanes as eluent to give the title compound as a colorless solid (72 mg, 04, 149.30, 147.37, 135.78, 131.99, 130.63, 128.59, 128.09, 121.09, 120.94, 114.91, 113.90, 110.13, 83.10, 27.43 06, 151.18, 132.25, 131.82, 131.03, 126.49, 125.44, 121.14, 111.88, 40.35; 69, 135.73, 130.61, 127.98, 126.71, 121.07, 120.57, 111.87, 110.09, 83.04, 77.31, 76.99, 76.68, 40.34, 27.43 36, 136.35, 135.60, 135.42, 132.61, 131.92, 130.17, 128.14, 125.89, 125.35, 124.95, 122.60, 119.98 17, 135.85, 135.35, 130.70, 129.39, 128.45, 128.01, 125.54, 124.66, 123.22, 122.60, 121.26, 118.96, 116.19, 110.77, 110.16, 83.16, 27.46 Expression and purification of unnatural amino acid-containing sfGFP mutants. BL21(DE3) cells were transformed with the pEvol-PylT-mmPylRS and pET-sfGFP-T65G/Y66G/Q204TAG plasmids. The cells were recovered in 1 mL SOC medium following transformation and incubated at 37 ºC for 1 hour before plating on LB agar plate containing chloramphenicol (Cam) (34 μg/mL) and ampicillin (Amp) (100 
di-tert-Butyl 2,2'-(2-(2-(4-acetamidophenyl)-2H-tetrazol-
